Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterations

Chromosomal translocations of the mixed-lineage leukemia (MLL) gene are common genetic events in acute leukemias. In acute myeloid leukemia (AML), the translocation t(9;11)(p22;q23) [subsequently referred to as t(9;11)], resulting in the MLL-MLLT3-fusion protein, is the most common translocation

• Publication year

  2014

• Venue

  Haematologica

• Publication date

  2014-05-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3324/haematol.2014.105544PMID 24859875PMCID PMC4116844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.

  2013influential reference
• Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.

  2013cited by this paper
• Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance

  2013cited by this paper
• Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights.

  2012cited by this paper
• BreakFusion: targeted assembly-based identification of gene fusions in whole transcriptome paired-end sequencing data

  2012cited by this paper
• A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

  2012cited by this paper
• Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing

  2011cited by this paper
• The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

  2011cited by this paper
• High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.

  2010cited by this paper
• Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis

  2010cited by this paper
• High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.

  2010influential reference
• Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia

  2009cited by this paper
• Reference alignment of SNP microarray signals for copy number analysis of tumors

  2009cited by this paper
• Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions

  2009cited by this paper
• Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• Review Articles (434 articles)

  2008influential reference
• Single nucleotide polymorphism microarray analysis of karyotypically normal acute myeloid leukemia reveals frequent copy number neutral loss of heterozygosity

  2008cited by this paper
• Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis.

  2008cited by this paper
• Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs.

  2008influential reference
• Circular binary segmentation for the analysis of array-based DNA copy number data.

  2004cited by this paper
• dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data

  2004cited by this paper
• Development of a real‐time RT‐PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia

  2003cited by this paper
• Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.

  1998cited by this paper
• An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.

  1996cited by this paper
• Classification of Tumours

  1930cited by this paper

• Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapies.

  2025cites this paper
• Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia

  2023cites this paper
• Induction of AML Preleukemic Fusion Genes in HSPCs and DNA Damage Response in Preleukemic Fusion Gene Positive Samples

  2021cites this paper
• Next generation epigenetic modulators to target myeloid neoplasms

  2021cites this paper
• Current Cytogenetic Abnormalities in Acute Myeloid Leukemia

  2020cites this paper
• Synergistic Targeting of FLT3 Mutations in AML via Combined Menin-MLL and FLT3 Inhibition.

  2020cites this paper
• Acute Leukemia of Myeloid, Lymphoid, and Ambiguous Lineage and Related Malignancies

  2020cites this paper
• An uncommon t(9;11)(p24;q22) with monoallelic loss of ATM and KMT2A genes in a child with myelodysplastic syndrome/acute myeloid leukemia who evolved from Fanconi anemia

  2018cites this paper
• Aberrant expression of ETS1 and ETS2 proteins in cancer.

  2018cites this paper
• Molecular studies reveal a MLL-MLLT3 gene fusion displaced in a case of childhood acute lymphoblastic leukemia with complex karyotype.

  2015cites this paper
• Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

  2014cites this paper
• Classification of the Acute Leukemias: Cytochemical and Morphologic Considerations

  2013cites this paper